A NEW AGE OF VALUE-BASED REIMBURSEMENT
Assuring Real-World Effectiveness of Precision Medicine
21st century medicines have become increasingly precise. As a result, therapeutic success has increased. However, the cost of a treatment failure has risen to unprecedented levels, including for patients. Hence there is a growing market need to ensure that costs follow delivered outcomes.
August has developed a suite of Outcomes-Based Financial Solutions(r) or OBFS, to address the market needs around affordability and performance uncertainty.
INTRODUCING
August offers financial solutions tied to patient outcomes.
August’s suite of Outcomes-Based Financial Solutions(r)
BENEFITS
Payers
Health plans and self-insured employers are used to paying for chronic therapies over time based on premiums collected annually. The emergence of these one-time therapies therefore challenges this way of working. August’s OBFS provides a solution for this that provides Health Insurers with the following:
COST MANAGEMENT
Help incur costs over time, rather than pay or recognize the costs upfront.
BROAD COVERAGE
Ensure the broadest group of your members can get access.
INSIGHT INTO VALUE
Understand how well the therapy is actually working for your members.
.
BENEFITS
BioPharma
It’s no small feat to bring a new therapeutic to market, and requires significant investment. On top of that, advanced therapies come with complex manufacturing and distribution needs. August supports the commercialization process to ensure smoother market adoption.
INNOVATION REWARDED UPFRONT
Realize full revenue after your product is used.
BROAD ACCESS
Remove restrictions on access, resulting from affordability and performance uncertainty concerns.
We Care, Deeply
Care is not just part of our name, it’s a mission statement.
We are driven to ensure that these transformative treatments will reach as many patients as possible.
Want to learn more?